Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
125.00    1.20 (0.97%)
Bid:
124.60
Ask:
125.00
Spread: 0.40 (0.321%)
Market Cap: £304.27m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

21 Jul 2022 07:00

RNS Number : 2094T
PureTech Health PLC
21 July 2022
 

21 July 2022

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

20 July 2022

Number of ordinary shares purchased:

60,212

Highest price paid per share:

194.00p

Lowest price paid per share:

193.00p

Volume weighted average price paid per share:

193.94p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 3,538,835 ordinary shares in treasury and has 285,072,285 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 285,072,285, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

 

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

20/07/2022

15:07:10

357

194

XLON

00310152003TRLO1.1.1

20/07/2022

15:07:05

41

194

AQXE

00310151987TRLO1.1.1

20/07/2022

15:07:02

115

193.8

XLON

00310151977TRLO1.1.1

20/07/2022

15:07:02

302

193.8

XLON

00310151976TRLO1.1.1

20/07/2022

15:06:09

37

194

AQXE

00310151629TRLO1.1.1

20/07/2022

15:06:09

37

194

AQXE

00310151628TRLO1.1.1

20/07/2022

15:06:08

413

194

CHIX

00310151625TRLO1.1.1

20/07/2022

15:06:08

445

194

CHIX

00310151623TRLO1.1.1

20/07/2022

15:06:06

357

194

XLON

00310151614TRLO1.1.1

20/07/2022

15:06:06

394

194

XLON

00310151612TRLO1.1.1

20/07/2022

15:06:06

357

194

XLON

00310151613TRLO1.1.1

20/07/2022

15:06:06

294

194

XLON

00310151611TRLO1.1.1

20/07/2022

15:06:06

394

194

XLON

00310151610TRLO1.1.1

20/07/2022

15:06:06

14

194

XLON

00310151608TRLO1.1.1

20/07/2022

15:06:06

49

194

XLON

00310151609TRLO1.1.1

20/07/2022

15:06:06

3416

194

XLON

00310151607TRLO1.1.1

20/07/2022

15:06:06

343

194

XLON

00310151606TRLO1.1.1

20/07/2022

15:06:06

8

194

XLON

00310151605TRLO1.1.1

20/07/2022

15:06:04

319

194

XLON

00310151539TRLO1.1.1

20/07/2022

15:06:04

16

194

XLON

00310151538TRLO1.1.1

20/07/2022

15:06:04

353

194

XLON

00310151537TRLO1.1.1

20/07/2022

15:06:04

114

194

XLON

00310151536TRLO1.1.1

20/07/2022

15:06:04

17

194

CHIX

00310151535TRLO1.1.1

20/07/2022

15:06:04

74

194

BATE

00310151527TRLO1.1.1

20/07/2022

15:06:04

60

194

CHIX

00310151524TRLO1.1.1

20/07/2022

15:06:04

46

194

CHIX

00310151526TRLO1.1.1

20/07/2022

15:06:04

60

194

CHIX

00310151525TRLO1.1.1

20/07/2022

15:06:04

12

194

CHIX

00310151522TRLO1.1.1

20/07/2022

15:06:04

57

194

CHIX

00310151523TRLO1.1.1

20/07/2022

15:06:04

71

194

CHIX

00310151520TRLO1.1.1

20/07/2022

15:06:04

60

194

CHIX

00310151521TRLO1.1.1

20/07/2022

15:06:04

71

194

CHIX

00310151517TRLO1.1.1

20/07/2022

15:06:04

71

194

CHIX

00310151518TRLO1.1.1

20/07/2022

15:06:04

67

194

BATE

00310151515TRLO1.1.1

20/07/2022

15:06:04

71

194

CHIX

00310151516TRLO1.1.1

20/07/2022

15:06:04

71

194

BATE

00310151513TRLO1.1.1

20/07/2022

15:06:04

82

194

BATE

00310151514TRLO1.1.1

20/07/2022

15:06:04

280

194

BATE

00310151511TRLO1.1.1

20/07/2022

15:06:04

142

194

BATE

00310151512TRLO1.1.1

20/07/2022

15:06:04

82

194

BATE

00310151510TRLO1.1.1

20/07/2022

15:06:04

71

194

BATE

00310151509TRLO1.1.1

20/07/2022

15:06:03

57

194

CHIX

00310151508TRLO1.1.1

20/07/2022

15:06:03

1299

194

BATE

00310151473TRLO1.1.1

20/07/2022

15:06:02

518

194

BATE

00310151468TRLO1.1.1

20/07/2022

15:06:02

227

194

XLON

00310151460TRLO1.1.1

20/07/2022

15:06:02

12

194

XLON

00310151459TRLO1.1.1

20/07/2022

15:06:02

335

194

XLON

00310151458TRLO1.1.1

20/07/2022

15:06:02

375

194

XLON

00310151457TRLO1.1.1

20/07/2022

15:06:02

131

194

XLON

00310151456TRLO1.1.1

20/07/2022

15:06:02

269

194

XLON

00310151455TRLO1.1.1

20/07/2022

15:06:02

204

194

XLON

00310151453TRLO1.1.1

20/07/2022

15:06:02

66

194

XLON

00310151454TRLO1.1.1

20/07/2022

15:06:02

407

194

XLON

00310151452TRLO1.1.1

20/07/2022

15:06:02

388

194

XLON

00310151451TRLO1.1.1

20/07/2022

15:06:02

388

194

XLON

00310151450TRLO1.1.1

20/07/2022

15:06:02

393

194

XLON

00310151449TRLO1.1.1

20/07/2022

15:06:02

301

194

XLON

00310151448TRLO1.1.1

20/07/2022

15:06:02

48

194

CHIX

00310151447TRLO1.1.1

20/07/2022

15:06:02

106

194

XLON

00310151446TRLO1.1.1

20/07/2022

15:06:02

336

194

XLON

00310151445TRLO1.1.1

20/07/2022

15:06:02

68

194

BATE

00310151444TRLO1.1.1

20/07/2022

15:06:02

17

194

CHIX

00310151443TRLO1.1.1

20/07/2022

15:06:02

354

194

XLON

00310151442TRLO1.1.1

20/07/2022

15:06:02

336

194

XLON

00310151441TRLO1.1.1

20/07/2022

15:05:39

344

194

BATE

00310151305TRLO1.1.1

20/07/2022

15:05:38

37

194

AQXE

00310151302TRLO1.1.1

20/07/2022

15:05:38

384

194

BATE

00310151303TRLO1.1.1

20/07/2022

15:05:38

37

194

AQXE

00310151301TRLO1.1.1

20/07/2022

15:05:13

44

194

AQXE

00310151213TRLO1.1.1

20/07/2022

15:05:13

44

194

AQXE

00310151212TRLO1.1.1

20/07/2022

15:05:13

314

194

BATE

00310151211TRLO1.1.1

20/07/2022

15:01:19

6

194

BATE

00310150067TRLO1.1.1

20/07/2022

15:01:19

23

194

BATE

00310150068TRLO1.1.1

20/07/2022

15:01:19

43

194

CHIX

00310150066TRLO1.1.1

20/07/2022

15:01:19

45

194

AQXE

00310150064TRLO1.1.1

20/07/2022

15:01:19

40

194

AQXE

00310150065TRLO1.1.1

20/07/2022

15:01:19

44

194

AQXE

00310150063TRLO1.1.1

20/07/2022

15:01:19

37

194

AQXE

00310150062TRLO1.1.1

20/07/2022

15:01:18

136

194

BATE

00310150061TRLO1.1.1

20/07/2022

15:01:18

40

194

AQXE

00310150060TRLO1.1.1

20/07/2022

15:00:04

67

194

BATE

00310149724TRLO1.1.1

20/07/2022

15:00:04

380

194

BATE

00310149725TRLO1.1.1

20/07/2022

14:33:20

246

193

CHIX

00310142892TRLO1.1.1

20/07/2022

14:33:20

66

193

CHIX

00310142890TRLO1.1.1

20/07/2022

14:33:20

94

193

AQXE

00310142891TRLO1.1.1

20/07/2022

14:33:19

47

193

AQXE

00310142888TRLO1.1.1

20/07/2022

14:33:19

68

193

CHIX

00310142889TRLO1.1.1

20/07/2022

14:33:19

47

193

AQXE

00310142887TRLO1.1.1

20/07/2022

14:32:59

379

193

CHIX

00310142704TRLO1.1.1

20/07/2022

14:31:40

549

193

CHIX

00310142166TRLO1.1.1

20/07/2022

14:31:40

736

193

CHIX

00310142165TRLO1.1.1

20/07/2022

14:31:40

68

193

CHIX

00310142164TRLO1.1.1

20/07/2022

14:31:39

40

193.4

AQXE

00310142162TRLO1.1.1

20/07/2022

14:31:39

37

193.4

AQXE

00310142163TRLO1.1.1

20/07/2022

14:31:39

45

193.4

AQXE

00310142161TRLO1.1.1

20/07/2022

14:31:39

45

193.4

AQXE

00310142160TRLO1.1.1

20/07/2022

14:31:39

45

193.4

AQXE

00310142159TRLO1.1.1

20/07/2022

14:31:39

621

193.4

AQXE

00310142158TRLO1.1.1

20/07/2022

14:31:38

6867

194

XLON

00310142155TRLO1.1.1

20/07/2022

14:31:38

5462

194

XLON

00310142156TRLO1.1.1

20/07/2022

14:31:38

336

194

XLON

00310142154TRLO1.1.1

20/07/2022

14:31:37

1552

194

XLON

00310142110TRLO1.1.1

20/07/2022

14:31:37

979

194

XLON

00310142109TRLO1.1.1

20/07/2022

14:31:37

832

194

XLON

00310142108TRLO1.1.1

20/07/2022

14:31:37

6288

194

XLON

00310142107TRLO1.1.1

20/07/2022

14:31:37

13955

194

XLON

00310142106TRLO1.1.1

20/07/2022

14:31:37

347

194

XLON

00310142105TRLO1.1.1

20/07/2022

14:31:35

26

194

XLON

00310142097TRLO1.1.1

20/07/2022

14:31:35

47

194

XLON

00310142096TRLO1.1.1

20/07/2022

14:31:35

796

194

XLON

00310142095TRLO1.1.1

20/07/2022

14:31:35

343

194

XLON

00310142094TRLO1.1.1

20/07/2022

14:31:24

439

193.4

AQXE

00310142024TRLO1.1.1

20/07/2022

14:06:23

470

193.4

AQXE

00310137432TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLDDDIIFIF
12345678910
Date   Source Headline
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MERL
Merlin Entertainments
LSE
0.00%
PXOG
PXOG.L
LSE
0.00%
OSEC
Octopus Aim 2
LSE
0.00%
AVAP
Avation
LSE
0.37%
PRD
Predator Oil
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
5.56%
PPP
Pennpetro Energy
LSE
0.00%
MPL
Mercantile Ports & Logistics
LSE
-13.79%
ITM
Itm Power
LSE
-7.38%
ECR
ECR Minerals
LSE
-12.50%